Empirical antifungal therapy - New options, new tradeoffs.

被引：46

作者：

Marr, KA ^{[1
]}

机构：

[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2002年 / 346卷 / 04期

关键词：

D O I：

10.1056/NEJM200201243460410

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：278 / 280

页数：3

共 10 条

[1] Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy - A randomized, controlled trial [J].

Boogaerts, M ;

Winston, DJ ;

Bow, EJ ;

Garber, G ;

Reboli, AC ;

Schwarer, AP ;

Novitzky, N ;

Boehme, A ;

Chwetzoff, E ;

De Beule, K .

ANNALS OF INTERNAL MEDICINE, 2001, 135 (06) :412-422

[2] A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia [J].

Malik, IA ;

Moid, I ;

Aziz, Z ;

Khan, S ;

Suleman, M .

AMERICAN JOURNAL OF MEDICINE, 1998, 105 (06) :478-483

[3]

MEUNIER F, 1989, AM J MED, V86, P668

[4] EMPIRIC ANTIBIOTIC AND ANTIFUNGAL THERAPY FOR CANCER-PATIENTS WITH PROLONGED FEVER AND GRANULOCYTOPENIA [J].

PIZZO, PA ;

ROBICHAUD, KJ ;

GILL, FA ;

WITEBSKY, FG .

AMERICAN JOURNAL OF MEDICINE, 1982, 72 (01) :101-111

[5] Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: A pragmatic, multicentre, prospective and randomised clinical trial [J].

Viscoli, C ;

Castagnola, E ;

VanLint, MT ;

Moroni, C ;

Garaventa, A ;

Rossi, MR ;

Fanci, R ;

Menichetti, F ;

Caselli, D ;

Giacchino, M ;

Congiu, M .

EUROPEAN JOURNAL OF CANCER, 1996, 32A (05) :814-820

[6] Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. [J].

Walsh, TJ ;

Pappas, P ;

Winston, DJ ;

Lazarus, HM ;

Petersen, F ;

Raffalli, J ;

Yanovich, S ;

Stiff, P ;

Greenberg, R ;

Donowitz, G ;

Lee, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :225-234

[7] Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia [J].

Walsh, TJ ;

Finberg, RW ;

Arndt, C ;

Hiemenz, J ;

Schwartz, C ;

Bodensteiner, D ;

Pappas, P ;

Seibel, N ;

Greenberg, RN ;

Dummer, S ;

Schuster, M ;

Holcenberg, JS .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) :764-771

[8] Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia [J].

White, MH ;

Bowden, RA ;

Sandler, ES ;

Graham, ML ;

Noskin, GA ;

Wingard, JR ;

Goldman, M ;

van Burik, JA ;

McCabe, A ;

Miller, CB ;

Gurwith, M ;

Carole, B .

CLINICAL INFECTIOUS DISEASES, 1998, 27 (02) :296-302

[9] A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia [J].

Wingard, JR ;

White, MH ;

Anaissie, E ;

Raffalli, J ;

Goodman, J ;

Arrieta, A .

CLINICAL INFECTIOUS DISEASES, 2000, 31 (05) :1155-1163

[10] A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer [J].

Winston, DJ ;

Hathorn, JW ;

Schuster, MG ;

Schiller, GJ ;

Territo, MC .

AMERICAN JOURNAL OF MEDICINE, 2000, 108 (04) :282-289

← 1 →